Background: Pediatric tumors of the central nervous system are the leading cause of cancer-related death among children. High-grade gliomas (HGGs) in children have a five-year survival rate of less than 20%. Due to their rarity, diagnosis is often delayed, treatment strategies rely on historical protocols, and clinical trials necessitate collaboration across multiple institutions.
Summary: The...